title: Psychotic Exacerbation Following Subcutaneous Leuprolide in a Male Patient With Previous History of Schizophrenia.
authors.affiliation: Brian.Mitchell@bcm.edu.|Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA.
authors.forename: Brian G
authors.initials: BG
authors.lastname: Mitchell
authors.affiliation: Department of Pharmacy, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
authors.forename: Ashley L
authors.initials: AL
authors.lastname: Adams
authors.affiliation: Department of Psychiatry, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
authors.forename: Poonam K
authors.initials: PK
authors.lastname: Thandi
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D011471:Prostatic Neoplasms / Q000150:complications / Q000628:therapy; D011618:Psychotic Disorders / Q000150:complications*; D012559:Schizophrenia / Q000150:complications*; D065566:Subcutaneous Absorption
chemical_list: D018931:Antineoplastic Agents, Hormonal; D016729:Leuprolide